| 拉米夫定联合胸腺肽α1治疗重型乙型肝炎的临床研究 |
| |
| 引用本文： | 王堂明,李玉龙,邱波,李树民,王云,张雪梅,邹荣. 拉米夫定联合胸腺肽α1治疗重型乙型肝炎的临床研究[J]. 国际流行病学传染病学杂志, 2007, 34(3): 156-158 |
| |
| 作者姓名： | 王堂明 李玉龙 邱波 李树民 王云 张雪梅 邹荣 |
| |
| 作者单位： | 617061,四川省攀枝花市第四人民医院(传染病医院)肝病治疗中心 |
| |
| 基金项目： | 攀枝花市科学技术局科研资助项目(2004~2006) |
| |
| 摘 要： | 目的观察拉米夫定(LAM)联合胸腺肽α1治疗重型乙型肝炎的疗效。方法选择重型乙型肝炎患者88例,治疗组44例用LAM联合胸腺肽α1治疗,对照组44例不作任何抗病毒及免疫调节治疗,两组均常规使用护肝、对症治疗。结果治疗组与对照组比较,生存率经统计学处理有显著差异(P<0.01)。结论LAM联合胸腺肽α1治疗重型乙型肝炎可明显降低患者死亡率,提高生存率,值得临床进一步研究。
|
| 关 键 词： | 拉米夫定 胸腺肽α_1 乙型肝炎 死亡率 |
Effect of lamivudine combined with thymosin-alpha 1 in the treatment of patients with severe hepatitis B |
| |
| WANG Tang-ming,LI Yu-long,QIU Bo,LI Shu-min,WANG Yun,ZHANG Xue-mei,ZOU Rong. Effect of lamivudine combined with thymosin-alpha 1 in the treatment of patients with severe hepatitis B[J]. International Journal of Epidemiology and Infectious Disease, 2007, 34(3): 156-158 |
| |
| Authors: | WANG Tang-ming LI Yu-long QIU Bo LI Shu-min WANG Yun ZHANG Xue-mei ZOU Rong |
| |
| Abstract: | Objective To explore the effect of lamivudine combined with thymosin-alpha 1 in the treatment of patients with severe hepatitis B. Method 88 cases patients with severe hepatitis B were selected, 44 patients in treatment group were received lamivudine combined with thymosin-alpha1, 44 patients in control group were received no antiviral treatment or immunity regulate. 2 groups were received ordinary synthetic treatment. Results Compared the treatment group with the control group, the survival rate had significantly difference(P<0.01). Conclusions Lamivudine combined with thymosin-alpha 1 in the treatment of patients with severe hepatitis B can effectively decrease the mortality and increase the survival rate of the patients. It is worth doing more systematic clinic study. |
| |
| Keywords: | Lamivudine Thymosin-alpha1 Hepatitis B Mortality |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
|
